BVS Stock Price, Chart, Stats & News

Bioventus Inc.
Save
612.44M
Market cap
22.05x
Current P/E
10.24x
Forward P/E
BVS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 67.32% |
Operating margin | 10.04% |
Pretax margin | 4.53% |
Net margin | 4.00% |
Effective tax rate | -6.09% |
ROA | 3.33% |
ROE | 13.79% |
D/E | 1.69x |
Interest coverage ratio | 2.15x |
BVS valuation
P/E | 22.05x |
P/S | 1.06x |
P/B | 3.24x |
P/CF | 7.98x |
P/FCF | 8.35x |
P/OCF | 7.98x |
PEG | 0.14x |
EV multiple | 3.24x |
About
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement.
Similar securities
Based on sector and market capitalization
Report issue











